Allergic rhinitis - a review on recent advances in characteristics, diagnostic and treatments
DOI:
https://doi.org/10.12775/JEHS.2023.13.02.025Keywords
Allergic rhinitis, Diagnosis, treatmentAbstract
Introduction:
Allergic rhinitis is an inflammation of the nasal mucosa characterized by nasal discharge or down the back of the throat, sneezing, stuffy or itchy nose. Allergic rhinitis can be caused by various allergens - pollen, house dust mites, animal allergens, fungi. It can occur periodically or chronically, as a year-round allergic rhinitis. Allergic rhinitis (AR) is a common condition, epidemiological studies suggest that it affects 20–30% of adults and up to 40% of children.
Objective:
The purpose of this review is to analyze the latest information on the characteristics, diagnosis and treatment of patients with allergic rhinitis.
Material and metods:
This review was based on available data collected in the PubMed data base. The research was done by looking through key words such as: “allergic rhinitis”, “Local nasal allergy”, “diagnosis” and “treatment”.
State of knowledge:
The main challenges with allergic rhinitis relate to its treatment. Symptomatic and anti-inflammatory drugs are often used and are not fully effective. The diagnosis of allergic rhinitis can be diagnosed by history and physical examination, with testing reserved for treatment of nonresponders.
Summary:
Treatment should be comprehensive and take into account the environment, pharmacotherapy, allergen immunotherapy, if indicated. As a disease that affects many people and significantly reduces the quality of life, allergic rhinitis deserves a thorough understanding of its symptoms, diagnosis and treatment.
References
E. Ridolo et al., “Quality of sleep in allergic children and their parents,” Allergol Immunopathol (Madr), vol. 43, no. 2, pp. 180–184, Mar. 2015, doi: 10.1016/j.aller.2014.01.004.
B. Leynaert et al., “Association between asthma and rhinitis according to atopic sensitization in a population-based study☆,” Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 86–93, Jan. 2004, doi: 10.1016/j.jaci.2003.10.010.
S. R. Durham et al., “Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet,” Journal of Allergy and Clinical Immunology, vol. 125, no. 1, pp. 131-138.e7, Jan. 2010, doi: 10.1016/j.jaci.2009.10.035.
C. Rondón et al., “Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis,” Journal of Allergy and Clinical Immunology, vol. 133, no. 4, pp. 1026–1031, Apr. 2014, doi: 10.1016/j.jaci.2013.10.034.
B. Sibbald and E. Rink, “Labelling of rhinitis and hayfever by doctors.,” Thorax, vol. 46, no. 5, pp. 378–381, May 1991, doi: 10.1136/thx.46.5.378.
M. I. Asher et al., “Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys,” The Lancet, vol. 368, no. 9537, pp. 733–743, Aug. 2006, doi: 10.1016/S0140-6736(06)69283-0.
E. O. Meltzer, “Allergic Rhinitis,” Immunol Allergy Clin North Am, vol. 36, no. 2, pp. 235–248, May 2016, doi: 10.1016/j.iac.2015.12.002.
M. D. Seidman et al., “Clinical Practice Guideline,” Otolaryngology–Head and Neck Surgery, vol. 152, no. 2, pp. 197–206, Feb. 2015, doi: 10.1177/0194599814562166.
L. Bielory et al., “Ocular and nasal allergy symptom burden in America: The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys,” Allergy Asthma Proc, vol. 35, no. 3, pp. 211–218, May 2014, doi: 10.2500/aap.2014.35.3750.
M. Smith, L. Cecchi, C. A. Skjøth, G. Karrer, and B. Šikoparija, “Common ragweed: A threat to environmental health in Europe,” Environ Int, vol. 61, pp. 115–126, Nov. 2013, doi: 10.1016/j.envint.2013.08.005.
B. Björkstén, T. Clayton, P. Ellwood, A. Stewart, D. Strachan, and the I. Phase III Study Group, “Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood,” Pediatric Allergy and Immunology, vol. 19, no. 2, pp. 110–124, Mar. 2008, doi: 10.1111/j.1399-3038.2007.00601.x.
J. L. Brożek et al., “Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision,” Journal of Allergy and Clinical Immunology, vol. 140, no. 4, pp. 950–958, Oct. 2017, doi: 10.1016/j.jaci.2017.03.050.
J. R. Harkema, S. A. Carey, and J. G. Wagner, “The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium,” Toxicol Pathol, vol. 34, no. 3, pp. 252–269, Apr. 2006, doi: 10.1080/01926230600713475.
P. Small and H. Kim, “Allergic rhinitis,” Allergy, Asthma & Clinical Immunology, vol. 7, no. S1, p. S3, Dec. 2011, doi: 10.1186/1710-1492-7-S1-S3.
M. S. Dykewicz and D. L. Hamilos, “Rhinitis and sinusitis,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S103–S115, Feb. 2010, doi: 10.1016/j.jaci.2009.12.989.
M. D. Scarupa and M. A. Kaliner, “Nonallergic Rhinitis, With a Focus on Vasomotor Rhinitis,” World Allergy Organization Journal, vol. 2, no. 3, pp. 20–25, 2009, doi: 10.1097/WAO.0b013e318196ca1e.
J. Bousquet et al., “Unmet needs in severe chronic upper airway disease (SCUAD),” Journal of Allergy and Clinical Immunology, vol. 124, no. 3, pp. 428–433, Sep. 2009, doi: 10.1016/j.jaci.2009.06.027.
K. E. Hermelingmeier, R. K. Weber, M. Hellmich, C. P. Heubach, and R. Mösges, “Nasal Irrigation as an Adjunctive Treatment in Allergic Rhinitis: A Systematic Review and Meta-analysis,” Am J Rhinol Allergy, vol. 26, no. 5, pp. e119–e125, Sep. 2012, doi: 10.2500/ajra.2012.26.3787.
K. E. Hermelingmeier, R. K. Weber, M. Hellmich, C. P. Heubach, and R. Mösges, “Nasal Irrigation as an Adjunctive Treatment in Allergic Rhinitis: A Systematic Review and Meta-analysis,” Am J Rhinol Allergy, vol. 26, no. 5, pp. e119–e125, Sep. 2012, doi: 10.2500/ajra.2012.26.3787.
C. Rondón et al., “Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial,” Allergy, vol. 71, no. 7, pp. 1057–1061, Jul. 2016, doi: 10.1111/all.12889.
C. E. Lamb et al., “Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective,” Curr Med Res Opin, vol. 22, no. 6, pp. 1203–1210, Jun. 2006, doi: 10.1185/030079906X112552.
M. D. Seidman et al., “Clinical Practice Guideline,” Otolaryngology–Head and Neck Surgery, vol. 152, no. 2, pp. 197–206, Feb. 2015, doi: 10.1177/0194599814562166.
B. Leynaert et al., “Association between asthma and rhinitis according to atopic sensitization in a population-based study☆,” Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 86–93, Jan. 2004, doi: 10.1016/j.jaci.2003.10.010.
J. Grainger and A. Drake-Lee, “Montelukast in allergic rhinitis: a systematic review and meta-analysis,” Clinical Otolaryngology, vol. 31, no. 5, pp. 360–367, Oct. 2006, doi: 10.1111/j.1749-4486.2006.01276.x.
H. Nolte et al., “Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets,” J Allergy Clin Immunol Pract, vol. 5, no. 1, pp. 84-89.e3, Jan. 2017, doi: 10.1016/j.jaip.2016.08.017.
O. A. Aboshady and K. M. Elghanam, “Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines,” Clin Exp Otorhinolaryngol, vol. 7, no. 4, p. 241, 2014, doi: 10.3342/ceo.2014.7.4.241.
A. S. Nayak, G. J. Atiee, E. Dige, J. Maloney, and H. Nolte, “Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis,” Allergy Asthma Proc, vol. 33, no. 5, pp. 404–410, Sep. 2012, doi: 10.2500/aap.2012.33.3605.
P. Demoly, W. Emminger, D. Rehm, V. Backer, L. Tommerup, and J. Kleine-Tebbe, “Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial,” Journal of Allergy and Clinical Immunology, vol. 137, no. 2, pp. 444-451.e8, Feb. 2016, doi: 10.1016/j.jaci.2015.06.036.
C. Rondón et al., “Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy,” Allergy, vol. 73, no. 4, pp. 905–915, Apr. 2018, doi: 10.1111/all.13350.
M. G. Stewart, “Epidemiology and burden of nasal congestion,” Int J Gen Med, p. 37, Feb. 2010, doi: 10.2147/IJGM.S8077.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aleksandra Lisowska, Ziemwowit Żaba, Wojciech Żołyniak, Paweł Warzyszak, Maria Milczek, Róża Małek, Izabela Hawranik, Mikołaj Tomasik, Szymon Niski, Mateusz Skrzypek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 518
Number of citations: 0
